0% found this document useful (0 votes)
224 views

Qualcomm Analyst Reports

The Analyst Report of Qualcomm for Q3FY24, which shares the detailed information of how the company is performing
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
224 views

Qualcomm Analyst Reports

The Analyst Report of Qualcomm for Q3FY24, which shares the detailed information of how the company is performing
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

J P M O R G A N North America Equity Research

31 July 2024

Qualcomm
F3Q24 Review: Upsides Through Diversification and Overweight
Premium Smartphone; F1Q25 Guide Softer But QCOM, QCOM US
Conservative Relative to Cyclical Drivers Price (31 Jul 24):$180.95
▼Price Target (Dec-25):$230.00
Prior (Dec-25):$235.00

The strength of the premium smartphone market in relation to Chinese OEMs as


well as upsides in the Autos and IoT businesses, which are critical to Qualcomm’s
efforts towards diversification of its end-markets, helped deliver results for F3Q
that exceeded investor expectations. Guidance for F4Q also tracked better than
feared despite a lot of choppiness in relation to benefits from an extra week and also IT Hardware/ Telecom & Networking
Equipment
relative to headwinds from the end of the license to ship to Huawei. And yet, even
as Qualcomm’s F3Q24 guidance was able to surpass investors’ expectations, Samik Chatterjee, CFA AC
(1-212) 622-0798
which had more recently been concerned around potential headwinds from a softer
[email protected]
China smartphone market following 6/18 promotions as well as the headwinds in
Joseph Cardoso
relation to Huawei, the early look provided by the company for F1Q25 tracked
(1-212) 622-9036
below investor expectations. While JPM and investor expectations were primed [email protected]
for double-digit revenue growth in F1Q25 and for FY25, Qualcomm is indicating Manmohanpreet Singh
early expectations for mid-single-digit growth; however, we believe that the early (1-212) 622-4527
guide embeds two significant areas of conservatism which investors should take [email protected]
note of and would go a long way in explaining the shortfall: 1) assumption that the Priyanka Thapa
global smartphone market tracks largely flat (to slightly up in 2024) and planning (1-212) 622-4935
assumptions remain for the same, even as data from 1H 2024 indicates that the [email protected]
smartphone market is up about 7% y/y; 2) assumption that the strength evidenced J.P. Morgan Securities LLC

with Chinese smartphone OEMs will not sustain in F1Q as inventory


replenishment will be limited against the backdrop of a limited recovery in the Key Changes (FYE Sep)
smartphone market. Relative to the underlying assumptions from Qualcomm, we Prev Cur
believe the cyclical recovery already seen in the smartphone market and the Adj. EPS - 25E ($) 12.00 11.30
potential volume opportunity from a AI-led replacement cycle could drive upsides
to Qualcomm’s outlined F1Q25 expectations. Moving beyond the Handset Quarterly Forecasts (FYE Sep)
business, the success of the diversification of the end-markets is bearing fruit and Adj. EPS ($)
was the primary contributor to upsides in the quarter as Autos and IoT both 2023A 2024E 2025E
Q1 2.37 2.75A 2.87
delivered stronger-than-expected growth, setting a higher baseline to envision Q2 2.15 2.44A 2.75
growth in the future in these key end-markets. We are trimming our revenue growth Q3 1.87 2.34A 2.70
expectations for FY25 to a high-single-digit growth percentage led by robust Q4 2.02 2.60 2.98
FY 8.43 10.13 11.30
growth in non-Handset revenues, although we still envision potential upside
opportunities from a better underlying smartphone market, and are trimming our Style Exposure
Dec-25 price target to $230 vs. $235 prior.

• F3Q24 (Jun-end) Results: Stronger revenue drove EPS above consensus


expectations. Revenues tracked to $9.4 bn vs. JPMe of $9.3 bn, consensus of
$9.2 bn, and guide of $8.8 - $9.6 bn, including QCT of $8.1 bn (vs. JPMe of
$8.0 bn, consensus of $7.9 bn, and guide of $7.5 - $8.1 bn), and QTL of $1.3
bn (vs. JPMe and consensus of $1.3 bn, and guide of $1.2 - $1.4 bn). QCT EBT
margins tracked to 27.0% (vs. JPMe of 26.0%, consensus of 26.4% and guide
of 25% - 27%), and QTL EBT margins tracked to 70.2% (vs. JPMe of 71.0%,
consensus of 70.5%, and guide of 69% - 73%). EPS tracked to $2.33 (vs. JPMe

Sources for: Style Exposure – J.P. Morgan Quantitative and Derivatives Strategy; all other tables are company data and J.P. Morgan estimates.

See page 8 for analyst certification and important disclosures.


J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that
the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single
factor in making their investment decision.

www.jpmorganmarkets.com
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Price Performance Summary Investment Thesis and Valuation


Investment Thesis
We rate QCOM shares Overweight, primarily on the opportunity
for upside from cyclical upside in the smartphone industry,
which has been impacted by consumer spending headwinds, as
well as diversification of its end markets beyond smartphones,
leveraging the technology leadership already demonstrated in
the smartphone market. The diversification into end markets of
automotive, IoT, PCs, AR/VR, etc. leverages the technology
developed for the smartphone market in relation to baseband
modems, application processors, and RF front end, helping in
YTD 1m 3m 12m providing sustainable growth drivers, which support double-
Abs 25.1% -9.2% 9.1% 36.9% digit revenue growth, in our view.
Rel 9.3% -10.3% -0.6% 16.6%
Valuation
Company Data
We reduce our December 2025 price target to $230 (vs. $235
Shares O/S (mn) 1,134
52-week range ($) 230.63-104.33 prior) based on a ~20x target P/E multiple on our updated FY27
Market cap ($ mn) 205,197.30 EPS estimate, which excludes majority of business from Apple,
Exchange rate 1.00 discounted back by one year. We believe a ~20x multiple is
Free float(%) 99.9%
3M - Avg daily vol (mn) 10.13 appropriate in reflection of robust earnings growth ex-Apple in
3M - Avg daily val ($ mn) 2,013.2 the medium term from the AI opportunity (smartphones as well
Volatility (90 Day) 44 as PCs) and execution relative to diversification.
Index S&P 500
BBG BUY|HOLD|SELL 28|15|1

Key Metrics (FYE Sep) Performance Drivers


$ in millions FY23A FY24E FY25E FY26E
Financial Estimates
Revenue 35,831 38,571 41,766 47,093
Adj. EBIT 11,461 13,287 14,430 16,524
Adj. EBITDA 13,270 14,978 16,226 18,543
Adj. net income 9,486 11,405 12,467 14,282
Adj. EPS 8.43 10.13 11.30 13.10
BBG EPS 8.30 9.93 11.34 12.52
Cashflow from operations 11,299 11,164 13,918 16,055
FCFF 12,134 10,576 12,829 14,753
Margins and Growth
Revenue Growth Y/Y (%) (18.9%) 7.6% 8.3% 12.8%
EBIT margin 32.0% 34.4% 34.6% 35.1%
EBIT growth (32.8%) 15.9% 8.6% 14.5%
EBITDA margin 37.0% 38.8% 38.9% 39.4%
EBITDA Growth Y/Y (%) (29.5%) 12.9% 8.3% 14.3%
Net margin 26.5% 29.6% 29.9% 30.3%
Adj. EPS growth (32.8%) 20.2% 11.6% 16.0%
Ratios
Adj. tax rate 14.3% 13.2% 13.0% 13.0%
Interest cover 19.2 22.0 24.3 27.8
Net debt/Equity 0.3 0.3 0.1 NM
Net debt/EBITDA 0.5 0.5 0.1 NM
ROE 47.9% 48.1% 43.5% 40.8%
Valuation
FCFF yield 6.0% 5.2% 6.4% 7.5%
Dividend yield - - - -
EV/Revenue 5.8 5.4 4.9 4.4
EV/EBITDA 15.6 13.8 12.7 11.1
Adj. P/E 21.5 17.9 16.0 13.8

Source: J.P. Morgan Quantitative and Derivatives Strategy for Performance Drivers; company data, Bloomberg Finance L.P. and J.P. Morgan estimates for all other tables. Note: Price history may not be
complete or exact.

2
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

of $2.26, consensus of $2.24, and guide of $2.15 - $2.35).


• F4Q24 (Sep-end) Guide: Revenue and EPS outlook better than feared even when
adjusted for extra week. Revenue was guided to $9.5-$10.3 bn (vs. JPMe/consensus of
$9.8 bn/$9.7 bn); however, adjusted for the extra week (14 weeks) in the September
quarter, guidance would have likely been slightly shy of sell-side consensus. While the
aggregate revenue guide might be slightly shy of sell-side consensus on adjusting for an
extra week, we believe the guidance is still better than feared as concerns around a
slowdown in the China post 6/18 had been mounting in recent weeks. The aggregate
revenue guidance comprises QCT revenues of $8.1-$8.7 bn (vs. JPMe /consensus of $8.4
bn/$8.3 bn) and QTL revenues of $1.35-$1.55 bn or $1.35 bn when adjusted for the extra
week (vs. JPMe and consensus of $1.4 bn). QCT EBT margin was guided to 27% - 29%
(vs JPMe of 26.0% and consensus of 28.0%) and QTL EBT margin was guided to 70%
- 74% (vs JPMe of 71.1% and consensus of 70.4%). EPS was guided to $2.45-$2.65 for
a midpoint of ~$2.55 (vs. JPMe of $2.42 and consensus of $2.45).
• F1Q25 (Dec-end) Guide: Implied revenue guidance below consensus, but also
appears to incorporate conservatism on multiple fronts. Qualcomm highlighted that
revenue growth in F1Q25 might look similar to F1Q24, i.e. 5% y/y , which is materially
below consensus expectation of +9% y/y , although it is important to keep in mind the base
case assumptions from the management team that are driving the forecast, including: 1)
Qualcomm is assuming a flat to slightly up global smartphone market despite healthy y/y
increases in the 1H of the calendar year and relative to our forecasts for 3% growth; and
2) Qualcomm assumes that Chinese OEMs, which have been a robust driver of growth
for Qualcomm, moderate in terms of growth in the December quarter as the pace of
growth and inventory replenishment evidenced in recent quarters is unlikely to sustain
if the overall smartphone recovery is limited; 3) Huawei revenue headwinds y/y
contributing about 2 ppts of headwinds.

3
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Investment Thesis, Valuation and Risks


Qualcomm (Overweight; Price Target: $230.00)
Investment Thesis
We rate QCOM shares Overweight, primarily on the opportunity for upside from cyclical
upside in the smartphone industry, which has been impacted by consumer spending
headwinds, as well as diversification of its end markets beyond smartphones leveraging the
technology leadership already demonstrated in the smartphone market. The diversification
into end markets of automotive, IoT, PCs, AR/VR, etc. leverages the technology developed
for the smartphone market in relation to baseband modems, application processors, and RF
front end, helping in providing sustainable growth drivers, which support double-digit
revenue growth, in our view.
Valuation
We reduce our December 2025 price target to $230 (vs. $235 prior) based on a ~20x target
P/E multiple on our updated FY27 EPS estimate, which excludes majority of business from
Apple, discounted back by one year. We believe a ~20x multiple is appropriate in reflection
of robust earnings growth ex-Apple in the medium term from the AI opportunity,
(smartphones as well as PCs) and execution relative to diversification.

Qualcomm P/E-Based Intrinsic Value

Source: J.P. Morgan estimates.

Risks to Rating and Price Target


Industry Downside Risks
Deceleration in the handset and smartphone market on pullback in consumer
spending. A worsening macro growth outlook could drive moderation in consumer

4
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

purchasing and result in a greater than expected contraction in the handset and smartphone
markets, the primary driver of Qualcomm’s earnings. Consumer spending pullback could
pose headwinds to our estimates and price target.

Company-Specific Downside Risks


Licensing disputes potentially leading to lower ongoing royalty revenues. Qualcomm’s
licensing model has been subjected to regulatory scrutiny in different jurisdictions, such as
Mainland China, Taiwan, Korea, Europe, and the United States. In some instances,
Qualcomm reached a settlement that resulted in a lower royalty rate charged from
smartphone OEMs (e.g., reached a settlement in China for $975 mn in February 2015).
Similar ongoing/potential litigation in other places, including the United States, could
present more downside risk in the form of monetary penalties as well as a lower royalty rate.

5
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Qualcomm Summary Table


$ in Millions, Except Per Share Data

Source: Company reports and J.P. Morgan estimates.

6
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Qualcomm: Summary of Financials


Income Statement - Annual FY22A FY23A FY24E FY25E FY26E Income Statement - Quarterly 1Q24A 2Q24A 3Q24A 4Q24E
Revenue 44,170 35,831 38,571 41,766 47,093 Revenue 9,922A 9,386A 9,391A 9,872
COGS (18,363) (15,647) (16,617) (18,717) (21,561) COGS (4,251)A (4,047)A (4,122)A (4,197)
Gross profit 25,807 20,184 21,954 23,050 25,532 Gross profit 5,671A 5,339A 5,269A 5,675
SG&A (2,019) (1,892) (1,977) (2,035) (2,082) SG&A (461)A (495)A (518)A (503)
Adj. EBITDA 18,829 13,270 14,978 16,226 18,543 Adj. EBITDA 4,057A 3,587A 3,436A 3,898
D&A (1,762) (1,809) (1,691) (1,796) (2,019) D&A (437)A (411)A (419)A (424)
Adj. EBIT 17,067 11,461 13,287 14,430 16,524 Adj. EBIT 3,620A 3,176A 3,017A 3,474
Net Interest (538) (691) (682) (668) (668) Net Interest (177)A (171)A (167)A (167)
Adj. PBT 16,597 11,070 13,141 14,322 16,416 Adj. PBT 3,585A 3,175A 3,034A 3,347
Tax (2,346) (1,584) (1,735) (1,855) (2,134) Tax (484)A (414)A (386)A (451)
Minority Interest - - - - - Minority Interest - - - -
Adj. Net Income 14,251 9,486 11,405 12,467 14,282 Adj. Net Income 3,101A 2,761A 2,648A 2,895
Reported EPS 12.53 8.43 10.13 11.30 13.10 Reported EPS 2.75A 2.44A 2.34A 2.60
Adj. EPS 12.53 8.43 10.13 11.30 13.10 Adj. EPS 2.75A 2.44A 2.34A 2.60
DPS - - - - - DPS - - - -
Payout ratio - - - - - Payout ratio - - - -
Shares outstanding 1,137 1,126 1,126 1,103 1,090 Shares outstanding 1,127A 1,130A 1,134A 1,113
Balance Sheet & Cash Flow Statement FY22A FY23A FY24E FY25E FY26E Ratio Analysis FY22A FY23A FY24E FY25E FY26E
Cash and cash equivalents 2,773 8,450 7,299 12,683 19,660 Gross margin 58.4% 56.3% 56.9% 55.2% 54.2%
Accounts receivable 5,643 3,183 4,310 4,790 4,964 EBITDA margin 42.6% 37.0% 38.8% 38.9% 39.4%
Inventories 6,341 6,422 5,059 5,371 5,567 EBIT margin 38.6% 32.0% 34.4% 34.6% 35.1%
Other current assets 5,967 4,409 6,594 6,594 6,594 Net profit margin 32.3% 26.5% 29.6% 29.9% 30.3%
Current assets 20,724 22,464 23,262 29,438 36,785
PP&E 5,168 5,042 4,714 4,589 4,454 ROE 101.9% 47.9% 48.1% 43.5% 40.8%
LT investments 0 0 0 0 0 ROA 31.6% 19.0% 22.0% 22.4% 22.9%
Other non current assets 23,122 23,534 24,665 24,665 24,665 ROCE 49.5% 27.9% 29.8% 29.1% 29.0%
Total assets 49,014 51,040 52,641 58,692 65,904 SG&A/Sales 4.6% 5.3% 5.1% 4.9% 4.4%
Net debt/equity 0.7 0.3 0.3 0.1 NM
Short term borrowings 1,945 914 1,364 1,364 1,364
Payables 3,796 1,912 2,070 2,417 2,505 P/E (x) 14.4 21.5 17.9 16.0 13.8
Other short term liabilities 6,125 6,802 5,004 5,104 5,140 P/BV (x) 11.4 9.4 7.9 6.3 5.1
Current liabilities 11,866 9,628 8,438 8,885 9,009 EV/EBITDA (x) 11.0 15.6 13.8 12.7 11.1
Long-term debt 13,537 14,484 13,190 13,190 13,190 Dividend Yield - - - - -
Other long term liabilities 5,598 5,347 5,134 5,134 5,134
Total liabilities 31,001 29,459 26,762 27,209 27,333 Sales/Assets (x) 1.0 0.7 0.7 0.8 0.8
Shareholders' equity 18,013 21,581 25,880 31,484 38,571 Interest cover (x) 35.0 19.2 22.0 24.3 27.8
Minority interests - - - - - Operating leverage 140.7% 174.0% 208.3% 103.9% 113.8%
Total liabilities & equity 49,014 51,040 52,641 58,692 65,904
Revenue y/y Growth 32.0% (18.9%) 7.6% 8.3% 12.8%
BVPS 15.84 19.17 22.98 28.54 35.39
EBITDA y/y Growth 41.0% (29.5%) 12.9% 8.3% 14.3%
y/y Growth 82.9% 21.0% 19.9% 24.2% 24.0%
Tax rate 14.1% 14.3% 13.2% 13.0% 13.0%
Net debt/(cash) 12,709 6,948 7,255 1,871 (5,106)
Adj. Net Income y/y Growth 45.3% (33.4%) 20.2% 9.3% 14.6%
EPS y/y Growth 46.8% (32.8%) 20.2% 11.6% 16.0%
Cash flow from operating activities 9,096 11,299 11,164 13,918 16,055
DPS y/y Growth - - - - -
o/w Depreciation & amortization 1,762 1,809 1,691 1,796 2,019
o/w Changes in working capital (7,740) 749 281 (345) (246)
Cash flow from investing activities (5,804) 762 (3,633) (1,671) (1,884)
o/w Capital expenditure (2,262) (1,323) (1,180) (1,671) (1,884)
as % of sales 5.1% 3.7% 3.1% 4.0% 4.0%
Cash flow from financing activities (7,196) (6,663) (8,756) (6,863) (7,195)
o/w Dividends paid (3,212) (3,462) (3,625) (3,863) (4,195)
o/w Net debt issued/(repaid) - - - - -
Net change in cash (3,904) 5,428 (1,224) 5,384 6,977
Adj. Free cash flow to firm 7,296 12,134 10,576 12,829 14,753
y/y Growth (19.9%) 66.3% (12.8%) 21.3% 15.0%
Source: Company reports and J.P. Morgan estimates.
Note: $ in millions (except per-share data).Fiscal year ends Sep. o/w - out of which

7
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Analyst Certification: The Research Analyst(s) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts
are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies,
with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report
accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the
Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the
Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFIA
requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion,
without undue influence or intervention.
All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector
Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.
Important Disclosures

Market Maker: J.P. Morgan Securities LLC makes a market in the securities of Qualcomm.
Market Maker/ Liquidity Provider: J.P. Morgan is a market maker and/or liquidity provider in the financial instruments of/related to
Qualcomm.
Client: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: Qualcomm.
Client/Non-Investment Banking, Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies)
as clients, and the services provided were non-investment-banking, securities-related: Qualcomm.
Client/Non-Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the
services provided were non-securities-related: Qualcomm.
Potential Investment Banking Compensation: J.P. Morgan expects to receive, or intends to seek, compensation for investment banking
services in the next three months from Qualcomm.
Non-Investment Banking Compensation Received: J.P. Morgan has received compensation in the past 12 months for products or services
other than investment banking from Qualcomm.
Debt Position: J.P. Morgan may hold a position in the debt securities of Qualcomm, if any.

Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium
reports and all J.P. Morgan–covered companies, and certain non-covered companies, by visiting https://www.jpmm.com/research/disclosures ,
calling 1-800-477-0406, or e-mailing [email protected] with your request.
Date Rating Price ($) Price Target
($)
04-Nov-21 OW 138.48 200
16-Nov-21 OW 168.51 225
02-Feb-22 OW 177.13 240
05-Apr-22 OW 153.81 205
14-Jul-22 OW 135.64 185
12-Oct-22 OW 110.03 190
03-Nov-22 OW 112.50 185
20-Dec-22 OW 112.61 160
04-May-23 OW 112.83 145
19-Jul-23 OW 122.86 159
03-Aug-23 OW 129.27 148
02-Oct-23 OW 111.06 135
02-Nov-23 OW 110.89 140
08-Jan-24 OW 136.73 173
31-Jan-24 OW 145.98 170
01-May-24 OW 165.85 185
26-Jul-24 OW 175.39 235

The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period.
J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated
Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe:
J.P. Morgan uses the following rating system: Overweight (over the duration of the price target indicated in this report, we expect this stock will

8
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

outperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); Neutral (over
the duration of the price target indicated in this report, we expect this stock will perform in line with the average total return of the stocks in the
Research Analyst’s, or the Research Analyst’s team’s, coverage universe); and Underweight (over the duration of the price target indicated in
this report, we expect this stock will underperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s
team’s, coverage universe. NR is Not Rated. In this case, J.P. Morgan has removed the rating and, if applicable, the price target, for this stock
because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the
price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-Australia and ex-India)
and U.K. small- and mid-cap Equity Research, each stock’s expected total return is compared to the expected total return of a benchmark
country market index, not to those Research Analysts’ coverage universe. If it does not appear in the Important Disclosures section of this report,
the certifying Research Analyst’s coverage universe can be found on J.P. Morgan’s Research website, https://www.jpmorganmarkets.com .
Coverage Universe: Chatterjee, Samik: Amphenol (APH), Apple (AAPL), Arista (ANET), CDW (CDW), Calix (CALX), Ciena (CIEN),
Cisco (CSCO), Coherent Corp (COHR), CommScope (COMM), Corning (GLW), Dell Technologies (DELL), F5 Inc (FFIV), Fabrinet (FN),
Flex Ltd (FLEX), HP Inc (HPQ), Hewlett Packard Enterprise (HPE), Infinera (INFN), Jabil Inc (JBL), Juniper Networks (JNPR), Keysight
Technologies (KEYS), Logitech International (LOGI), Lumentum (LITE), Mobileye (MBLY), NetApp, Inc. (NTAP), Qualcomm (QCOM),
Sensata (ST), Stratasys, Ltd. (SSYS), Super Micro (SMCI), TE Connectivity (TEL), Teradyne (TER), Wolfspeed Inc (WOLF), Xerox Holdings
Corp (XRX)

J.P. Morgan Equity Research Ratings Distribution, as of July 06, 2024


Overweight Neutral Underweight
(buy) (hold) (sell)
J.P. Morgan Global Equity Research Coverage* 49% 38% 13%
IB clients** 49% 46% 34%
JPMS Equity Research Coverage* 48% 41% 11%
IB clients** 69% 66% 50%

*Please note that the percentages may not add to 100% because of rounding.
**Percentage of subject companies within each of the "buy," "hold" and "sell" categories for which J.P. Morgan has provided
investment banking services within the previous 12 months.
For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Neutral rating falls
into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation
are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies,
please see the most recent company-specific research report at http://www.jpmorganmarkets.com , contact the primary analyst or your J.P.
Morgan representative, or email [email protected] . For material information about the proprietary models used,
please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are available to download on
the company pages of our client website, http://www.jpmorganmarkets.com . This report also sets out within it the material underlying
assumptions used.
A history of J.P. Morgan investment recommendations disseminated during the preceding 12 months can be accessed on the Research &
Commentary page of http://www.jpmorganmarkets.com where you can also search by analyst name, sector or financial instrument.
Analysts' Compensation:The research analysts responsible for the preparation of this report receive compensation based upon various factors,
including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.
Other Disclosures

J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide.
UK MIFID FICC research unbundling exemption: UK clients should refer to UK MIFID Research Unbundling exemption for details of J.P.
Morgan’s implementation of the FICC research exemption and guidance on relevant FICC research categorisation.
All research material made available to clients are simultaneously available on our client website, J.P. Morgan Markets, unless specifically
permitted by relevant laws. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research
material available on a particular stock, please contact your sales representative.
Any long form nomenclature for references to China; Hong Kong; Taiwan; and Macau within this research material are Mainland China; Hong
Kong SAR (China); Taiwan (China); and Macau SAR (China).
J.P. Morgan Research may, from time to time, write on issuers or securities targeted by economic or financial sanctions imposed or administered
by the governmental authorities of the U.S., EU, UK or other relevant jurisdictions (Sanctioned Securities). Nothing in this report is intended to
be read or construed as encouraging, facilitating, promoting or otherwise approving investment or dealing in such Sanctioned Securities. Clients
should be aware of their own legal and compliance obligations when making investment decisions.

9
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

Any digital or crypto assets discussed in this research report are subject to a rapidly changing regulatory landscape. For relevant regulatory
advisories on crypto assets, including bitcoin and ether, please see https://www.jpmorgan.com/disclosures/cryptoasset-disclosure .
The author(s) of this research report may not be licensed to carry on regulated activities in your jurisdiction and, if not licensed, do not hold
themselves out as being able to do so.
Exchange-Traded Funds (ETFs): J.P. Morgan Securities LLC (“JPMS”) acts as authorized participant for substantially all U.S.-listed ETFs. To
the extent that any ETFs are mentioned in this report, JPMS may earn commissions and transaction-based compensation in connection with the
distribution of those ETF shares and may earn fees for performing other trade-related services, such as securities lending to short sellers of the
ETF shares. JPMS may also perform services for the ETFs themselves, including acting as a broker or dealer to the ETFs. In addition, affiliates
of JPMS may perform services for the ETFs, including trust, custodial, administration, lending, index calculation and/or maintenance and other
services.
Options and Futures related research: If the information contained herein regards options- or futures-related research, such information is
available only to persons who have received the proper options or futures risk disclosure documents. Please contact your J.P. Morgan
Representative or visit https://www.theocc.com/components/docs/riskstoc.pdf for a copy of the Option Clearing Corporation's Characteristics
and Risks of Standardized Options or http://www.finra.org/sites/default/files/Security_Futures_Risk_Disclosure_Statement_2018.pdf for a copy
of the Security Futures Risk Disclosure Statement.
Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future
become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please
consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates
Private Bank Clients: Where you are receiving research as a client of the private banking businesses offered by JPMorgan Chase & Co. and its
subsidiaries (“J.P. Morgan Private Bank”), research is provided to you by J.P. Morgan Private Bank and not by any other division of J.P. Morgan,
including, but not limited to, the J.P. Morgan Corporate and Investment Bank and its Global Research division.
Legal entity responsible for the production and distribution of research: The legal entity identified below the name of the Reg AC Research
Analyst who authored this material is the legal entity responsible for the production of this research. Where multiple Reg AC Research Analysts
authored this material with different legal entities identified below their names, these legal entities are jointly responsible for the production of
this research. Research Analysts from various J.P. Morgan affiliates may have contributed to the production of this material but may not be
licensed to carry out regulated activities in your jurisdiction (and do not hold themselves out as being able to do so). Unless otherwise stated
below, this material has been distributed by the legal entity responsible for production. If you have any queries, please contact the relevant
Research Analyst in your jurisdiction or the entity in your jurisdiction that has distributed this research material.
Legal Entities Disclosures and Country-/Region-Specific Disclosures:
Argentina: JPMorgan Chase Bank N.A Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (“BCRA”- Central
Bank of Argentina) and Comisión Nacional de Valores (“CNV”- Argentinian Securities Commission - ALYC y AN Integral N°51). Australia:
J.P. Morgan Securities Australia Limited (“JPMSAL”) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by the Australian
Securities and Investments Commission and is a Market Participant of ASX Limited, a Clearing and Settlement Participant of ASX Clear Pty
Limited and a Clearing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of
JPMSAL only to "wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be
found by visiting https://www.jpmm.com/research/disclosures . J.P. Morgan seeks to cover companies of relevance to the domestic and
international investor base across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation
sizes. If applicable, in the course of conducting public side due diligence on the subject company(ies), the Research Analyst team may at times
perform such diligence through corporate engagements such as site visits, discussions with company representatives, management presentations,
etc. Research issued by JPMSAL has been prepared in accordance with J.P. Morgan Australia’s Research Independence Policy which can be
found at the following link: J.P. Morgan Australia - Research Independence Policy . Brazil: Banco J.P. Morgan S.A. is regulated by the
Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Ombudsman J.P. Morgan: 0800-7700847 / 0800-7700810 (For
Hearing Impaired) / [email protected] . Canada: J.P. Morgan Securities Canada Inc. is a registered investment dealer,
regulated by the Canadian Investment Regulatory Organization and the Ontario Securities Commission and is the participating member on
Canadian exchanges. This material is distributed in Canada by or on behalf of J.P.Morgan Securities Canada Inc. Chile: Inversiones J.P. Morgan
Limitada is an unregulated entity incorporated in Chile. China: J.P. Morgan Securities (China) Company Limited has been approved by CSRC
to conduct the securities investment consultancy business. Dubai International Financial Centre (DIFC): JPMorgan Chase Bank, N.A., Dubai
Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - The
Gate, West Wing, Level 3 and 9 PO Box 506551, Dubai, UAE. This material has been distributed by JP Morgan Chase Bank, N.A., Dubai
Branch to persons regarded as professional clients or market counterparties as defined under the DFSA rules. European Economic Area
(EEA): Unless specified to the contrary, research is distributed in the EEA by J.P. Morgan SE (“JPM SE”), which is authorised as a credit
institution by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and jointly supervised by the
BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). JPM SE is a company headquartered in
Frankfurt with registered address at TaunusTurm, Taunustor 1, Frankfurt am Main, 60310, Germany. The material has been distributed in the
EEA to persons regarded as professional investors (or equivalent) pursuant to Art. 4 para. 1 no. 10 and Annex II of MiFID II and its respective
implementation in their home jurisdictions (“EEA professional investors”). This material must not be acted on or relied on by persons who are
not EEA professional investors. Any investment or investment activity to which this material relates is only available to EEA relevant persons
and will be engaged in only with EEA relevant persons. Hong Kong: J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is

10
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong, and J.P. Morgan Broking (Hong
Kong) Limited (CE number AAB027) is regulated by the Securities and Futures Commission in Hong Kong. JP Morgan Chase Bank, N.A.,
Hong Kong Branch (CE Number AAL996) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission, is
organized under the laws of the United States with limited liability. Where the distribution of this material is a regulated activity in Hong Kong,
the material is distributed in Hong Kong by or through J.P. Morgan Securities (Asia Pacific) Limited and/or J.P. Morgan Broking (Hong Kong)
Limited. India: J.P. Morgan India Private Limited (Corporate Identity Number - U67120MH1992FTC068724), having its registered office at
J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz - East, Mumbai – 400098, is registered with the Securities and Exchange Board of India
(SEBI) as a ‘Research Analyst’ having registration number INH000001873. J.P. Morgan India Private Limited is also registered with SEBI as a
member of the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited (SEBI Registration Number –
INZ000239730) and as a Merchant Banker (SEBI Registration Number - MB/INM000002970). Telephone: 91-22-6157 3000, Facsimile: 91-22-
6157 3990 and Website: http://www.jpmipl.com . JPMorgan Chase Bank, N.A. - Mumbai Branch is licensed by the Reserve Bank of India (RBI)
(Licence No. 53/ Licence No. BY.4/94; SEBI - IN/CUS/014/ CDSL : IN-DP-CDSL-444-2008/ IN-DP-NSDL-285-2008/ INBI00000984/
INE231311239) as a Scheduled Commercial Bank in India, which is its primary license allowing it to carry on Banking business in India and
other activities, which a Bank branch in India are permitted to undertake. For non-local research material, this material is not distributed in India
by J.P. Morgan India Private Limited. Compliance Officer: Spurthi Gadamsetty; [email protected] ; +912261573225.
Grievance Officer: Ramprasadh K, [email protected] ; +912261573000.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration
granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of
returns to investors.
Indonesia: PT J.P. Morgan Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is registered and supervised by the Otoritas
Jasa Keuangan (OJK). Korea: J.P. Morgan Securities (Far East) Limited, Seoul Branch, is a member of the Korea Exchange (KRX). JPMorgan
Chase Bank, N.A., Seoul Branch, is licensed as a branch office of foreign bank (JPMorgan Chase Bank, N.A.) in Korea. Both entities are
regulated by the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS). For non-macro research material, the
material is distributed in Korea by or through J.P. Morgan Securities (Far East) Limited, Seoul Branch. Japan: JPMorgan Securities Japan Co.,
Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in Japan. Malaysia: This material is issued
and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X), which is a Participating Organization of Bursa Malaysia
Berhad and holds a Capital Markets Services License issued by the Securities Commission in Malaysia. Mexico: J.P. Morgan Casa de Bolsa,
S.A. de C.V. and J.P. Morgan Grupo Financiero are members of the Mexican Stock Exchange and are authorized to act as a broker dealer by the
National Banking and Securities Exchange Commission. New Zealand: This material is issued and distributed by JPMSAL in New Zealand
only to "wholesale clients" (as defined in the Financial Markets Conduct Act 2013). JPMSAL is registered as a Financial Service Provider under
the Financial Service providers (Registration and Dispute Resolution) Act of 2008. Philippines: J.P. Morgan Securities Philippines Inc. is a
Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities
Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Singapore: This material is issued and distributed in
Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS) [MCI (P) 030/08/2023 and Co. Reg. No.: 199405335R],
which is a member of the Singapore Exchange Securities Trading Limited, and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB
Singapore), both of which are regulated by the Monetary Authority of Singapore. This material is issued and distributed in Singapore only to
accredited investors, expert investors and institutional investors, as defined in Section 4A of the Securities and Futures Act, Cap. 289 (SFA).
This material is not intended to be issued or distributed to any retail investors or any other investors that do not fall into the classes of
“accredited investors,” “expert investors” or “institutional investors,” as defined under Section 4A of the SFA. Recipients of this material in
Singapore are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection with, the material. South Africa:
J.P. Morgan Equities South Africa Proprietary Limited and JPMorgan Chase Bank, N.A., Johannesburg Branch are members of the
Johannesburg Securities Exchange and are regulated by the Financial Services Conduct Authority (FSCA). Taiwan: J.P. Morgan Securities
(Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau.
Material relating to equity securities is issued and distributed in Taiwan by J.P. Morgan Securities (Taiwan) Limited, subject to the license scope
and the applicable laws and the regulations in Taiwan. According to Paragraph 2, Article 7-1 of Operational Regulations Governing Securities
Firms Recommending Trades in Securities to Customers (as amended or supplemented) and/or other applicable laws or regulations, please note
that the recipient of this material is not permitted to engage in any activities in connection with the material that may give rise to conflicts of
interests, unless otherwise disclosed in the “Important Disclosures” in this material. Thailand: This material is issued and distributed in
Thailand by JPMorgan Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of
Finance and the Securities and Exchange Commission, and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok
10500. UK: Unless specified to the contrary, research is distributed in the UK by J.P. Morgan Securities plc (“JPMS plc”) which is a member of
the London Stock Exchange and is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the
Prudential Regulation Authority. JPMS plc is registered in England & Wales No. 2711006, Registered Office 25 Bank Street, London, E14 5JP.
This material is directed in the UK only to: (a) persons having professional experience in matters relating to investments falling within article
19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) (Order) 2005 (“the FPO”); (b) persons outlined in article 49 of the
FPO (high net worth companies, unincorporated associations or partnerships, the trustees of high value trusts, etc.); or (c) any persons to whom
this communication may otherwise lawfully be made; all such persons being referred to as "UK relevant persons". This material must not be
acted on or relied on by persons who are not UK relevant persons. Any investment or investment activity to which this material relates is only
available to UK relevant persons and will be engaged in only with UK relevant persons. Research issued by JPMS plc has been prepared in
accordance with JPMS plc's policy for prevention and avoidance of conflicts of interest related to the production of Research which can be
found at the following link: J.P. Morgan EMEA - Research Independence Policy . U.S.: J.P. Morgan Securities LLC (“JPMS”) is a member of

11
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

the NYSE, FINRA, SIPC, and the NFA. JPMorgan Chase Bank, N.A. is a member of the FDIC. Material published by non-U.S. affiliates is
distributed in the U.S. by JPMS who accepts responsibility for its content.
General: Additional information is available upon request. The information in this material has been obtained from sources believed to be
reliable. While all reasonable care has been taken to ensure that the facts stated in this material are accurate and that the forecasts, opinions and
expectations contained herein are fair and reasonable, JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) make
no representations or warranties whatsoever to the completeness or accuracy of the material provided, except with respect to any disclosures
relative to J.P. Morgan and the Research Analyst's involvement with the issuer that is the subject of the material. Accordingly, no reliance should
be placed on the accuracy, fairness or completeness of the information contained in this material. There may be certain discrepancies with data
and/or limited content in this material as a result of calculations, adjustments, translations to different languages, and/or local regulatory
restrictions, as applicable. These discrepancies should not impact the overall investment analysis, views and/or recommendations of the subject
company(ies) that may be discussed in the material. J.P. Morgan accepts no liability whatsoever for any loss arising from any use of this material
or its contents, and neither J.P. Morgan nor any of its respective directors, officers or employees, shall be in any way responsible for the contents
hereof, apart from the liabilities and responsibilities that may be imposed on them by the relevant regulatory authority in the jurisdiction in
question, or the regulatory regime thereunder. Opinions, forecasts or projections contained in this material represent J.P. Morgan's current
opinions or judgment as of the date of the material only and are therefore subject to change without notice. Periodic updates may be provided on
companies/industries based on company-specific developments or announcements, market conditions or any other publicly available
information. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or projections, which
represent only one possible outcome. Furthermore, such opinions, forecasts or projections are subject to certain risks, uncertainties and
assumptions that have not been verified, and future actual results or events could differ materially. The value of, or income from, any
investments referred to in this material may fluctuate and/or be affected by changes in exchange rates. All pricing is indicative as of the close of
market for the securities discussed, unless otherwise stated. Past performance is not indicative of future results. Accordingly, investors may
receive back less than originally invested. This material is not intended as an offer or solicitation for the purchase or sale of any financial
instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not
intended as recommendations of particular securities, financial instruments or strategies to particular clients. This material may include views on
structured securities, options, futures and other derivatives. These are complex instruments, may involve a high degree of risk and may be
appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks involved. The recipients of
this material must make their own independent decisions regarding any securities or financial instruments mentioned herein and should seek
advice from such independent financial, legal, tax or other adviser as they deem necessary. J.P. Morgan may trade as a principal on the basis of
the Research Analysts’ views and research, and it may also engage in transactions for its own account or for its clients’ accounts in a manner
inconsistent with the views taken in this material, and J.P. Morgan is under no obligation to ensure that such other communication is brought to
the attention of any recipient of this material. Others within J.P. Morgan, including Strategists, Sales staff and other Research Analysts, may take
views that are inconsistent with those taken in this material. Employees of J.P. Morgan not involved in the preparation of this material may have
investments in the securities (or derivatives of such securities) mentioned in this material and may trade them in ways different from those
discussed in this material. This material is not an advertisement for or marketing of any issuer, its products or services, or its securities in any
jurisdiction.
Confidentiality and Security Notice: This transmission may contain information that is privileged, confidential, legally privileged, and/or
exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying,
distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this
transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is
received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase &
Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in
error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. This message is
subject to electronic monitoring: https://www.jpmorgan.com/disclosures/email
MSCI: Certain information herein (“Information”) is reproduced by permission of MSCI Inc., its affiliates and information providers (“MSCI”)
©2024. No reproduction or dissemination of the Information is permitted without an appropriate license. MSCI MAKES NO EXPRESS OR
IMPLIED WARRANTIES (INCLUDING MERCHANTABILITY OR FITNESS) AS TO THE INFORMATION AND DISCLAIMS ALL
LIABILITY TO THE EXTENT PERMITTED BY LAW. No Information constitutes investment advice, except for any applicable Information
from MSCI ESG Research. Subject also to msci.com/disclaimer
Sustainalytics: Certain information, data, analyses and opinions contained herein are reproduced by permission of Sustainalytics and: (1)
includes the proprietary information of Sustainalytics; (2) may not be copied or redistributed except as specifically authorized; (3) do not
constitute investment advice nor an endorsement of any product or project; (4) are provided solely for informational purposes; and (5) are not
warranted to be complete, accurate or timely. Sustainalytics is not responsible for any trading decisions, damages or other losses related to it or
its use. The use of the data is subject to conditions available at https://www.sustainalytics.com/legal-disclaimers . ©2024 Sustainalytics. All
Rights Reserved.
"Other Disclosures" last revised July 06, 2024.

Copyright 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or
redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P.
Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party

12
Samik Chatterjee, CFA AC North America Equity Research
(1-212) 622-0798 31 July 2024 JPMORGAN
[email protected]

artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P.
Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to
prevent any and all access to or use of such J.P. Morgan Data by any third-party. #$J&098$#*P
Completed 31 Jul 2024 10:55 PM EDT Disseminated 31 Jul 2024 10:55 PM EDT

13

You might also like